Drug Testing Locations - Arlington, SD

Drug Testing in Arlington, SD

Arlington, South Dakota Statistics

In 2022, Brookings County, where Arlington is located, reported a 5% increase in drug abuse cases.

Approximately 13% of high school students in Arlington, SD, have tried illicit drugs at least once.

The arrest rate for drug-related offenses in Arlington saw a 7% rise over the past year.

Prescription drug misuse accounts for about 25% of all drug abuse cases in Brookings County.

Methamphetamine is the most commonly abused illicit drug in Arlington and surrounding areas.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Arlington, SD & Drug Testing Policies

Employers in Arlington, SD, have implemented stringent drug testing policies to maintain a drug-free workplace. These policies often include pre-employment screenings and random checks for current employees, which are essential deterrents to drug use. Local businesses adhere to guidelines issued by the U.S. Department of Labor, ensuring practices align with federal standards.

State and local laws require employers to provide assistance programs for employees struggling with substance abuse. Many companies offer Employee Assistance Programs (EAPs) that provide confidential counseling and support. More information about these policies can be found at the South Dakota Department of Human Services.

Government Efforts with Drug Problems in Arlington, SD

The government is actively addressing drug problems in Arlington, SD, through various initiatives. At the local level, the Arlington Police Department collaborates with community groups to educate the public on drug abuse. State efforts include legislation aimed at reducing opioid prescriptions and expanding treatment options. Further details can be found at the South Dakota Department of Social Services.

The federal government supports these efforts by providing grants for the establishment of rehabilitation centers in South Dakota. These initiatives are part of a broader strategy to curb drug abuse across the nation, providing resources for both prevention and treatment. Check out the Substance Abuse and Mental Health Services Administration for more federal support details.

Local Drug Busts & News in Arlington, SD

Arlington, SD, has seen several significant drug busts in recent years, primarily targeting methamphetamine distribution networks. In collaboration with the Brookings County Sheriff's Office, the Arlington Police successfully dismantled a local drug ring in 2022. This operation led to the arrest of multiple suspects and the seizure of substantial quantities of drugs.

Community events focused on drug awareness have been organized in Arlington, bringing together law enforcement and residents. These events aim to educate the public about the dangers of drug abuse and encourage cooperation between citizens and police. The annual "Arlington Drug Awareness Day" is a key event in these efforts, fostering community resilience against drug-related issues.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Arlington, SD. Trusted by employers nationwide for accurate results and exceptional service.

South Dakota DOT/Non DOT Physicals

South Dakota Vision Tests

South Dakota Audiograms

South Dakota Respirator Fit Tests

South Dakota Lift Tests

South Dakota Background Checks

Clinical Testing Services

TB Testing in SD

Diabetes Testing in SD

Infectious Disease Testing in SD

Sickle Cell Anemia Testing in SD

Women/Men's Health Testing in SD

Resources & Citations

Project Recovery

Helpline Center

Boys & Girls Club of Watertown

Hope Haven

Friendship Village

Hinson Consulting Group

Iowan TBS

National Alliance on Mental Illness

Drug Testing Near Arlington, SD

Rutland, SD

Hayti, SD

De Smet, SD

Estelline, SD

Brookings, SD

Erwin, SD

Lake Norden, SD

Nunda, SD

Bruce, SD

Oldham, SD

Lake Preston, SD

Volga, SD

Sinai, SD

Badger, SD

Hetland, SD

Frequently Asked Questions

Customer Reviews